Aquigen Bio Sciences is pioneering a new era of sustainable biotechnology to meet the rising global demand for advanced scientific solutions while reinforcing critical pharmaceutical and industrial supply chains. As a leading Contract Research Organization (CRO), Aquigen is setting benchmarks in innovation, reliability, and safety across the biotech industry.
“Our mission has always been to empower researchers and innovators worldwide,” said the CEO of Aquigen Bio Sciences. “By combining sustainable practices with scientific rigor, we provide solutions that our clients can truly trust—from APIs & Intermediates to advanced impurity standards and custom synthesis projects.”
Innovation in API & Intermediates
Aquigen specializes in the design and optimization of synthetic routes for research-grade molecules across pharma, nutraceutical, cosmetic, and biotech sectors. Backed by experienced chemists and modern infrastructure, the company delivers high-quality APIs & intermediates, ensuring reliability, scalability, and regulatory compliance at every R&D stage.
Comprehensive Impurity Standards Portfolio
To meet the growing demand for precise impurity profiling, Aquigen offers a world-class range of impurity standards, including degradation products, process impurities, medicinal chemistry building blocks, and nitrosamines (NDMA, NDEA, NMBA). Each product is supplied with comprehensive characterization data for accuracy and regulatory compliance.
Aquigen is also recognized as a trusted global supplier of nicotine impurity standards, delivering high-purity reference materials to pharmaceutical industries worldwide.
Custom Synthesis & Deuterated Compounds
Beyond catalog products, Aquigen is a leader in custom synthesis, developing bespoke molecules to accelerate client research programs. The company also has strong expertise in deuterated labelled compounds, essential for advanced pharmacokinetic studies.
Building Supply Chain Resilience
In response to pandemic-driven supply chain challenges, Aquigen focuses on transparency, sustainability, and responsiveness to ensure reliable access to rare reference standards and complex molecules like Lenacapavir impurities, vital for antiviral drug development.
Technical Infrastructure
-
17,000 sq. ft. facility in Pune, producing at milligram to kilogram scales
-
Dedicated R&D center with 50+ scientists
-
State-of-the-art tools: HPLC, NMR, MS, QC systems
-
Expertise in impurities, nitrosamines, peptides, degradation products, and intermediates
The Way Forward
Serving clients across 25+ countries, Aquigen Bio Sciences is positioned to lead the next phase of sustainable biotech innovation. With regulatory-ready solutions, fast turnaround custom synthesis, and a global reach, Aquigen continues to empower pharmaceutical progress—shaping a healthier and more sustainable future.
Explore the full portfolio at www.aquigenbio.com
Contact:
Aquigen Bio Sciences Pvt Ltd
Pune, Maharashtra 412108
+91 7030123794 | bd@aquigenbio.com
